MicroRNAs in Atrial Fibrillation: Pathophysiological Aspects and Potential Biomarkers
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia associated with increased morbidity and mortality. The pathophysiological mechanisms underlying the development of AF are not entirely clear. In addition, there are no optimal biomarkers for the early detection and prognosis fo...
Saved in:
Published in: | International journal of biomedicine Vol. 10; no. 3; pp. 198 - 205 |
---|---|
Main Authors: | , |
Format: | Journal Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
01-09-2020
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia associated with increased morbidity and mortality. The pathophysiological mechanisms underlying the development of AF are not entirely clear. In addition, there are no optimal biomarkers for the early detection and prognosis for patients with AF. Emerging studies have uncovered a role for miRNAs in the initiation and maintenance of CVD. This review discusses the role of miRNAs in the pathogenesis of AF as well as the possibility of using miRNAs as biomarkers for detecting and predicting AF. |
---|---|
ISSN: | 2158-0510 2158-0529 |
DOI: | 10.21103/Article10(3)_RA3 |